Publisher
Springer Science and Business Media LLC
Subject
Infectious Diseases,Microbiology (medical),General Medicine
Reference80 articles.
1. Aslam B, Wang W, Arshad MI, Khurshid M, Muzammil S, Rasool MH, et al. Antibiotic resistance: a rundown of a global crisis. Infect Drug Resist. 2018;11:1645. https://doi.org/10.2147/IDR.S173867.
2. Al-Tawfiq JA, Stephens G, Memish ZA. Inappropriate antimicrobial use and potential solutions: a Middle Eastern perspective. Expert Rev Anti Infect Ther. 2010;8:765–74. https://doi.org/10.1586/eri.10.56.
3. Towse A, Hoyle CK, Goodall J, Hirsch M, Mestre-Ferrandiz J, Rex JH. Time for a change in how new antibiotics are reimbursed: development of an insurance framework for funding new antibiotics based on a policy of risk mitigation. Health Policy 2017;121:1025–30. https://doi.org/10.1016/J.HEALTHPOL.2017.07.011.
4. FDA. Novel drug approvals for 2017 n.d. https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2017. Accessed 20 Nov 2020.
5. Medicines Agency E. European Medicines Agency decision P/0148/2018 of 18 May 2018 on the review of a granted waiver for delafloxacin (EMEA-001080-PIP01–10). n.d.
Cited by
56 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献